Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase.
The association of B7-1/CD28 between antigen presenting cells (APCs) and T-cells provides a second signal to proliferate and activate T-cell immunity at the induction phase. Many reports indicate that tumor cells transfected with B7-1 induced augmented antitumor immunity at the induction phase by mi...
Main Authors: | Xiao-Lin Li, Marjolein Sluijter, Elien M Doorduijn, Shubha P Kale, Harris McFerrin, Yong-Yu Liu, Yan Li, Madhusoodanan Mottamal, Xin Yao, Fengkun Du, Baihan Gu, Kim Hoang, Yen H Nguyen, Nichelle Taylor, Chelsea R Stephens, Thorbald van Hall, Qian-Jin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4226464?pdf=render |
Similar Items
-
Economics of Singapore's RMA
by: Kuah, Adrian W. J
Published: (2008) -
T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1b with TAP-Independent Peptides Are Semi-Invariant Lymphocytes
by: Elien M. Doorduijn, et al.
Published: (2018-01-01) -
Reconsidering the Diachrony of Tone in Rma
by: Nathaniel A. Sims
Published: (2020-01-01) -
An efficient version of the RMA-11 model
by: Pablo Ezzatti, et al.
Published: (2011-08-01) -
4IR : the RMA we are finally looking for?
by: Bitzinger, Richard A.
Published: (2021)